Preoperative Warming, Hypothermia and Functional Recovery in Total Hip Arthroplasty

November 9, 2022 updated by: Michele Carella, University of Liege

Effect of Preoperative Warming on Intraoperative Hypothermia and Postoperative Functional Recovery Outcomes in Direct Anterior-approached Total Hip Arthroplasty: a Randomized Clinical Trial

This prospective, randomized, single-center study compares intraoperative heat loss at the core temperature level in patients scheduled for direct anterior total hip arthroplasty under general anesthesia and who will or will not, according to randomization, receive one hour of pre-warming with a pulsed air thermal blanket prior to anesthesia induction.

Study Overview

Detailed Description

In patients undergoing surgery, intraoperative hypothermia can occur because of anesthesia-induced inhibition of thermoregulation and heat loss associated with the patient's exposure to an environment maintained at a temperature below normal skin temperature.

Randomized trials show that even mild hypothermia results in serious complications, including surgical wound infection, coagulopathy and increased blood transfusions, and delayed postoperative recovery.

All products used during general anesthesia profoundly alter thermoregulatory control, reducing the activation thresholds of the main defenses against cold, which are the closure of the arteriovenous shunt and the generation of shivering. Impaired thermoregulation, combined with a cold operating room environment and direct-anterior hip surgical approach and exposure, causes hypothermia in almost all unheated patients.

The body core temperature is finely tuned to maintain an average of 37°C by balancing heat gain and loss. The nasopharynx is an excellent alternative to patient core temperature monitoring when esophageal monitoring is excluded for surgical reasons or blocked by an airway protected by an airway device.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Liège, Belgium, 4000
        • CHU de Liège

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA 1-2-3
  • Scheduled for direct anterior-approached total hip replacement surgery under general anesthesia

Exclusion Criteria:

  • pregnant women
  • patients with:

    1. peripheral neuropathy or other severe neurological pathology
    2. immunosuppression
    3. chronic renal insufficiency or severe hepatic insufficiency
    4. major congenital or acquired hemostasis disorders
    5. craniofacial dysmorphism or anatomical alterations of the upper airways
    6. known thermoregulatory disorders
  • patients with a preoperative body temperature > 37.5°C.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Group C

Patients undergoing total hip replacement surgery by anterior approach, with general anesthesia and continuous core body temperature measurement via nasopharyngeal thermic probe.

Patients recruited for surgery who will not receive the 30 minutes of preoperative warming through pulsed air thermal coverage.

Experimental: Group W

Patients undergoing total hip replacement surgery by anterior approach, with general anesthesia and continuous core body temperature measurement via nasopharyngeal thermic probe.

Patients recruited for surgery who will receive the 30 minutes of preoperative warming through pulsed air thermal coverage.

Patients enrolled in surgery who will not receive 30 minutes of pulsed air thermal blanket warming prior to induction of anesthesia (3M™ Bair Hugger™ Adult Integral Blanket, Model 300 Dimensions: 213 cm x 91 cm)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core body temperature
Time Frame: Intraoperative
Variation of core body temperature during surgery, i.e. the difference between the temperature at the time of induction of general anaesthesia and the minimum temperature recorded during the procedure, as well as its evolution over time.
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative blood loss
Time Frame: Intraoperative
Total intraoperative blood loss
Intraoperative
Shivering
Time Frame: First 6 hours after surgery
The incidence of shivering in the first 6 hours post-surgery
First 6 hours after surgery
Patient comfort
Time Frame: First 6 hours after surgery
Comfort in the recovery room by visual analogical scale (VAS 0-100)
First 6 hours after surgery
Patient comfort
Time Frame: First 6 hours after surgery
Length of stay in the recovery room
First 6 hours after surgery
Surgical site infection
Time Frame: 30 days after surgery
Incidence of surgical site infection at 30 days postoperative
30 days after surgery
Postoperative complications
Time Frame: 3 days after surgery
The occurrence of side effects related to hypothermia (cardiovascular, infectious and hemorrhagic complications)
3 days after surgery
QoR-15
Time Frame: Day-1 and Day-3 after surgery
Postoperative patient satisfaction and functional outcome (QoR-15 at D1 and D3)
Day-1 and Day-3 after surgery
LoS
Time Frame: 30 days after surgery
Length of stay in hospital
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2022

Primary Completion (Actual)

October 19, 2022

Study Completion (Actual)

October 20, 2022

Study Registration Dates

First Submitted

January 3, 2022

First Submitted That Met QC Criteria

January 15, 2022

First Posted (Actual)

January 28, 2022

Study Record Updates

Last Update Posted (Actual)

November 10, 2022

Last Update Submitted That Met QC Criteria

November 9, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Thermo-ATHA22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothermia; Anesthesia

Clinical Trials on Preoperative warming

Subscribe